Revisão Acesso aberto Revisado por pares

Local drug delivery for the prevention of restenosis. Fact, fancy, and future.

1994; Lippincott Williams & Wilkins; Volume: 90; Issue: 4 Linguagem: Inglês

10.1161/01.cir.90.4.2070

ISSN

1524-4539

Autores

A. Michael Lincoff, Eric J. Topol, Stephen G. Ellis,

Tópico(s)

Coronary Interventions and Diagnostics

Resumo

HomeCirculationVol. 90, No. 4Local drug delivery for the prevention of restenosis. Fact, fancy, and future. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBLocal drug delivery for the prevention of restenosis. Fact, fancy, and future. A M Lincoff, E J Topol and S G Ellis A M LincoffA M Lincoff Department of Cardiology, Cleveland Clinic Foundation, OH 44195. , E J TopolE J Topol Department of Cardiology, Cleveland Clinic Foundation, OH 44195. and S G EllisS G Ellis Department of Cardiology, Cleveland Clinic Foundation, OH 44195. Originally published1 Oct 1994https://doi.org/10.1161/01.CIR.90.4.2070Circulation. 1994;90:2070–2084 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Vachharajani T, Taliercio J and Anvari E (2021) New Devices and Technologies for Hemodialysis Vascular Access: A Review, American Journal of Kidney Diseases, 10.1053/j.ajkd.2020.11.027, 78:1, (116-124), Online publication date: 1-Jul-2021. McMonagle M (2020) The quest for effective pharmacological suppression of neointimal hyperplasia, Current Problems in Surgery, 10.1016/j.cpsurg.2020.100807, 57:8, (100807), Online publication date: 1-Aug-2020. Sakamoto A, Torii S, Jinnouchi H, Virmani R and Finn A (2018) Histopathologic and physiologic effect of overlapping vs single coronary stents: impact of stent evolution, Expert Review of Medical Devices, 10.1080/17434440.2018.1515012, 15:9, (665-682), Online publication date: 2-Sep-2018. Wang Y, Larsson M, Huang W, Chiou S, Nicholls S, Chao J and Liu D (2016) The use of polymer-based nanoparticles and nanostructured materials in treatment and diagnosis of cardiovascular diseases: Recent advances and emerging designs, Progress in Polymer Science, 10.1016/j.progpolymsci.2016.01.002, 57, (153-178), Online publication date: 1-Jun-2016. Sen Gupta A (2016) Cardiovascular Nanomedicine: Materials and Technologies Nanomaterials in Pharmacology, 10.1007/978-1-4939-3121-7_13, (251-277), . Thomas A (2016) Targeting Therapies to Treat Vein Graft Disease and Restenosis Coronary Graft Failure, 10.1007/978-3-319-26515-5_65, (715-723), . Rao S, Tan A, Thomas N and Prestidge C (2014) Perspective and potential of oral lipid-based delivery to optimize pharmacological therapies against cardiovascular diseases, Journal of Controlled Release, 10.1016/j.jconrel.2014.05.013, 193, (174-187), Online publication date: 1-Nov-2014. Krokidis M, Spiliopoulos S, Katsanos K and Sabharwal T (2012) Peripheral Applications of Drug-Coated Balloons: Past, Present and Future, CardioVascular and Interventional Radiology, 10.1007/s00270-012-0467-0, 36:2, (281-291), Online publication date: 1-Apr-2013. Saiz E, Zimmermann E, Lee J, Wegst U and Tomsia A (2013) Perspectives on the role of nanotechnology in bone tissue engineering, Dental Materials, 10.1016/j.dental.2012.08.001, 29:1, (103-115), Online publication date: 1-Jan-2013. Liistro F, Grotti S, Porto I, Angioli P, Ricci L, Ducci K, Falsini G, Ventoruzzo G, Turini F, Bellandi G and Bolognese L (2013) Drug-Eluting Balloon in Peripheral Intervention for the Superficial Femoral Artery, JACC: Cardiovascular Interventions, 10.1016/j.jcin.2013.07.010, 6:12, (1295-1302), Online publication date: 1-Dec-2013. Thomas A (2012) Targeted Treatments for Restenosis and Vein Graft Disease, ISRN Vascular Medicine, 10.5402/2012/710765, 2012, (1-23), Online publication date: 9-Dec-2012. Croce K, Costa M and Simon D (2012) Restenosis Textbook of Interventional Cardiology, 10.1016/B978-1-4377-2358-8.00032-2, (421-431), . Gupta A (2011) Nanomedicine approaches in vascular disease: a review, Nanomedicine: Nanotechnology, Biology and Medicine, 10.1016/j.nano.2011.04.001, 7:6, (763-779), Online publication date: 1-Dec-2011. Sudheer S, Prathibha S, Kothwala D, Engineer C, Raval A, Jerriwala A and Kotadia H (2009) Laser Raman spectroscopic investigations of biodegradable vehicle of active agents eluting LVM 316 stainless steel cardiovascular stents for in vivo degradation characteristics , Journal of Raman Spectroscopy, 10.1002/jrs.2457, 41:4, (363-369), Online publication date: 1-Apr-2010. Bicknell K, Surry E and Brooks G (2010) Targeting the cell cycle machinery for the treatment of cardiovascular disease, Journal of Pharmacy and Pharmacology, 10.1211/002235703765344487, 55:5, (571-591), Online publication date: 18-Feb-2010. Togashi D and Ryder A (2010) Assessing protein–surface interactions with a series of multi-labeled BSA using fluorescence lifetime microscopy and Förster Energy Resonance Transfer, Biophysical Chemistry, 10.1016/j.bpc.2010.07.006, 152:1-3, (55-64), Online publication date: 1-Nov-2010. Sharma S, Kukreja N, Christopoulos C and Gorog D (2014) Drug-eluting balloon: new tool in the box, Expert Review of Medical Devices, 10.1586/erd.10.5, 7:3, (381-388), Online publication date: 1-May-2010. Laham R (2010) Percutaneous Treatment of Coronary Artery Disease Device Therapy in Heart Failure, 10.1007/978-1-59745-424-7_10, (263-286), . Lim S, Bae E, Jeong M, Kim J, Hong Y, Sim D, Kim Y, Park I, Ahn Y, Song S, Cho D, Kim K and Kang J (2009) The effect of alpha lipoic acid in a porcine in-stent restenosis model, Journal of Cardiology, 10.1016/j.jjcc.2009.06.005, 54:3, (375-385), Online publication date: 1-Dec-2009. De Labriolle A, Pakala R, Bonello L, Lemesle G, Scheinowitz M and Waksman R (2009) Paclitaxel-eluting balloon: From bench to bed, Catheterization and Cardiovascular Interventions, 10.1002/ccd.21895, 73:5, (643-652), Online publication date: 1-Apr-2009. Herdeg C, Goehring-Frischholz K, Zuern C, Geisler T, Hartmann U, Hoevelborn T, Haase K and Gawaz M (2008) Local catheter-based delivery of antithrombotic or antiproliferative drugs: A new concept for prevention of restenosis, Thrombosis Research, 10.1016/j.thromres.2008.02.015, 123:2, (236-243), Online publication date: 1-Dec-2008. Rugonyi S (2008) Effect of Blood Flow on Near-the-Wall Mass Transport of Drugs and Other Bioactive Agents: A Simple Formula to Estimate Boundary Layer Concentrations, Journal of Biomechanical Engineering, 10.1115/1.2899571, 130:2, Online publication date: 1-Apr-2008. Varshosaz J and Soheili M (2008) Production and in vitro characterization of lisinopril-loaded nanoparticles for the treatment of restenosis in stented coronary arteries , Journal of Microencapsulation, 10.1080/02652040802054679, 25:7, (478-486), Online publication date: 1-Oct-2008. Sheiban I, Anselmino M, Moretti C, Biondi-Zoccai G, Galloni M, Vignolini C, Mattoni M, Sciuto F, Omedè P and Trevi G (2008) Effect of a novel drug-eluted balloon coated with Genistein before stent implantation in porcine coronary arteries, Clinical Research in Cardiology, 10.1007/s00392-008-0705-2, 97:12, (891-898), Online publication date: 1-Dec-2008. Jain J, Chitkara D and Kumar N (2008) Polyanhydrides as localized drug delivery carrier: an update, Expert Opinion on Drug Delivery, 10.1517/17425247.5.8.889, 5:8, (889-907), Online publication date: 1-Aug-2008. Moyer C, Berger P and White C (2007) Drug-Eluting Coronary Stents Cardiovascular Medicine, 10.1007/978-1-84628-715-2_48, (1031-1050), . Albrecht T, Speck U, Baier C, Wolf K, B??hm M and Scheller B (2007) Reduction of Stenosis Due to Intimal Hyperplasia After Stent Supported Angioplasty of Peripheral Arteries by Local Administration of Paclitaxel in Swine, Investigative Radiology, 10.1097/RLI.0b013e31804f5a60, 42:8, (579-585), Online publication date: 1-Aug-2007. Herdeg C, Göhring-Frischholz K, Geisler T, May A, Haase K and Gawaz M (2007) GENIE™ catheter for liquid local drug delivery, EuroIntervention, 10.4244/EIJV3I2A49, 3:2, (286-288), Online publication date: 1-Aug-2007. Soares J, Moore J and Rajagopal K (2007) Theoretical Modeling of Cyclically Loaded, Biodegradable Cylinders Modeling of Biological Materials, 10.1007/978-0-8176-4411-6_4, (125-177), . Sachar R and Topol E Local Gene and Cell Delivery Devices Essentials of Restenosis, 10.1007/978-1-59745-001-0_27, (419-442) Hong Y, Jeong M, Lee S, Hong S, Kim K, Park H, Kim J, Kim W, Ahn Y, Cho J, Park J and Kang J (2007) Anti-inflammatory Effect of Abciximab-Coated Stent in a Porcine Coronary Restenosis Model, Journal of Korean Medical Science, 10.3346/jkms.2007.22.5.802, 22:5, (802), . Cohen-Sela E, Elazar V, Epstein-Barash H and Golomb G (2007) Nano-Carriers of Drugs and Genes for the Treatment of Restenosis Nanoparticulate Drug Delivery Systems, 10.1201/9781420008449.ch15, (235-269), Online publication date: 30-Mar-2007. Zweers M, Engbers G, Grijpma D and Feijen J (2006) Release of anti-restenosis drugs from poly(ethylene oxide)-poly(dl-lactic-co-glycolic acid) nanoparticles, Journal of Controlled Release, 10.1016/j.jconrel.2006.05.021, 114:3, (317-324), Online publication date: 1-Sep-2006. Jain J, Modi S, Domb A and Kumar N (2005) Role of polyanhydrides as localized drug carriers, Journal of Controlled Release, 10.1016/j.jconrel.2004.12.021, 103:3, (541-563), Online publication date: 1-Apr-2005. van der Hoeven B, Pires N, Warda H, Oemrawsingh P, van Vlijmen B, Quax P, Schalij M, van der Wall E and Jukema J (2005) Drug-eluting stents: results, promises and problems, International Journal of Cardiology, 10.1016/j.ijcard.2004.01.021, 99:1, (9-17), Online publication date: 1-Mar-2005. Prasad C, Resmi K, Krishnan L and Vaishnav R (2016) Survival of Endothelial Cells in vitro on Paclitaxel-loaded Coronary Stents, Journal of Biomaterials Applications, 10.1177/0885328205047397, 19:4, (271-286), Online publication date: 1-Apr-2005. Tiukinhoy S, Khan A, Huang S, Klegerman M, MacDonald R and McPherson D (2004) Novel Echogenic Drug-Immunoliposomes for Drug Delivery, Investigative Radiology, 10.1097/01.rli.0000111207.92580.44, 39:2, (104-110), Online publication date: 1-Feb-2004. Kalinowski M, Alfke H, Hamann C, Viehofer K, Klose K, Barry J and Wagner H (2004) Effects of altering infusion parameters on intimal hyperplasia following local catheter-based delivery into the rabbit iliac artery, Atherosclerosis, 10.1016/j.atherosclerosis.2003.09.025, 172:1, (71-78), Online publication date: 1-Jan-2004. Sadeghi H and O'Neill W (2004) Local intramural delivery of 60% ethyl alcohol for treatment of recalcitrant in-stent restenosis, Catheterization and Cardiovascular Interventions, 10.1002/ccd.10794, 61:3, (396-399), Online publication date: 1-Mar-2004. Kavanagh C, Rochev Y, Gallagher W, Dawson K and Keenan A (2004) Local drug delivery in restenosis injury: thermoresponsive co-polymers as potential drug delivery systems, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2003.01.001, 102:1, (1-15), Online publication date: 1-Apr-2004. Joung Y, Kim H, Kim S, Chung K, Jang Y and Park K (2003) Estrogen release from metallic stent surface for the prevention of restenosis, Journal of Controlled Release, 10.1016/S0168-3659(03)00305-5, 92:1-2, (83-91), Online publication date: 1-Sep-2003. Schöber W, Wiskirchen J, Kehlbach R, Gebert R, Rodegerdts E, Betsch A, Johst U, Claussen C and Duda S (2002) Flufenamic Acid: Growth Modulating Effects on Human Aortic Smooth Muscle Cells In Vitro, Journal of Vascular and Interventional Radiology, 10.1016/S1051-0443(07)60014-1, 13:1, (89-96), Online publication date: 1-Jan-2002. Peerlings C, Hanssen H, Bevers R, Boelen E, Stelt B, Korthagen E and Koole L (2002) Heparin release from slippery-when-wet guide wires for intravascular use, Journal of Biomedical Materials Research, 10.1002/jbm.10381, 63:6, (692-698), . Yasuda S, Kanna M, Sakuragi S, Kojima S, Nakayama Y, Miyazaki S, Matsuda T, Kangawa K and Nonogi H (2002) Local Delivery of Single Low-Dose of C-Type Natriuretic Peptide, an Endogenous Vascular Modulator, Inhibits Neointimal Hyperplasia in a Balloon-Injured Rabbit Iliac Artery Model, Journal of Cardiovascular Pharmacology, 10.1097/00005344-200206000-00002, 39:6, (784-788), Online publication date: 1-Jun-2002. KATAOKA T, HONDA Y, BONNEAU H, YOCK P and FITZGERALD P (2002) New Catheter-Based Technology for the Treatment of Restenosis, Journal of Interventional Cardiology, 10.1111/j.1540-8183.2002.tb01070.x, 15:5, (371-379), Online publication date: 1-Oct-2002. Duda S, Wiesinger B, Koenig C, Wiskirchen J, Dietrich T and Tepe G (2009) A clinical survey of vascular stents, Minimally Invasive Therapy & Allied Technologies, 10.1080/136457002760273412, 11:4, (193-201), Online publication date: 1-Jan-2002. Crocker I and Robinson K (2002) Rationale for coronary artery radiation therapy, Seminars in Radiation Oncology, 10.1053/S1053-4296(02)80021-2, 12:1, (3-16), Online publication date: 1-Jan-2002. Kober G (2002) Akut-und Langzeitergebnisse Interventionelle Gefäßtherapie, 10.1007/978-3-642-57540-2_6, (67-88), . Lestini B, Sagnella S, Xu Z, Shive M, Richter N, Jayaseharan J, Case A, Kottke-Marchant K, Anderson J and Marchant R (2002) Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery, Journal of Controlled Release, 10.1016/S0168-3659(01)00505-3, 78:1-3, (235-247), Online publication date: 1-Jan-2002. Garachemani A, Fleisch M, Windecker S, Pfiffner D and Meier B (2002) Heparin and coumadin versus acetylsalicylic acid for prevention of restenosis after coronary angioplasty, Catheterization and Cardiovascular Interventions, 10.1002/ccd.10084, 55:3, (315-320), Online publication date: 1-Mar-2002. Kanamasa K, Inoue Y, Otani N, Naito N, Morii H, Ikeda A, Taniguchi M, Ishida N, Hayashi T and Ishikawa K (2016) tPA via Infusion Catheters Followed by Continuous IV Infusion for 3 Days Prevents Intimal Hyperplasia After Balloon Injury, Angiology, 10.1177/000331970105201203, 52:12, (819-825), Online publication date: 1-Dec-2001. TEPE G, DUDA S, KALINOWSKI M, KAMENZ J, BREHME U, HANKE H, CLAUSSEN C, BARES R, BAUMBACH A and DINKELBORG L (2001) Local Intra-Arterial Drug Delivery for Prevention of Restenosis, Investigative Radiology, 10.1097/00004424-200105000-00001, 36:5, (245-249), Online publication date: 1-May-2001. Park Y, Liang J, Yang Z and Yang V (2001) Controlled release of clot-dissolving tissue-type plasminogen activator from a poly(l-glutamic acid) semi-interpenetrating polymer network hydrogel, Journal of Controlled Release, 10.1016/S0168-3659(01)00360-1, 75:1-2, (37-44), Online publication date: 1-Jul-2001. Hong M (2001) Review : Restenosis Following Coronary Angioplasty : Current Status, The Korean Journal of Internal Medicine, 10.3904/kjim.2001.16.2.51, 16:2, (51-55) Herdeg C, Oberhoff M, Baumbach A, Blattner A, Axel D, Schröder S, Heinle H and Karsch K (2000) Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo, Journal of the American College of Cardiology, 10.1016/S0735-1097(00)00614-8, 35:7, (1969-1976), Online publication date: 1-Jun-2000. Maillard L, Van Belle E, Tio F, Rivard A, Kearney M, Branellec D, Steg P, Isner J and Walsh K (2000) Effect of percutaneous adenovirus-mediated Gax gene delivery to the arterial wall in double-injured atheromatous stented rabbit iliac arteries, Gene Therapy, 10.1038/sj.gt.3301255, 7:16, (1353-1361), Online publication date: 1-Aug-2000. Richey T, Iwata H, Oowaki H, Uchida E, Matsuda S and Ikada Y (2000) Surface modification of polyethylene balloon catheters for local drug delivery, Biomaterials, 10.1016/S0142-9612(99)00281-1, 21:10, (1057-1065), Online publication date: 1-May-2000. Lehmann K, Popma J, Werner J, Lansky A and Wilensky R (2000) Vascular remodeling and the local delivery of cytochalasin B after coronary angioplasty in humans, Journal of the American College of Cardiology, 10.1016/S0735-1097(99)00603-8, 35:3, (583-591), Online publication date: 1-Mar-2000. Fishbein I, Chorny M and Golomb G (2000) Treatment of restenosis by controlled‐release delivery systems of tyrphostins, Drug Development Research, 10.1002/1098-2299(200007/08)50:3/4 3.0.CO;2-#, 50:3-4, (487-496), Online publication date: 1-Jul-2000. Kandarpa K (2000) Catheter-based Techniques for Endovascular Local Drug Delivery, Journal of Vascular and Interventional Radiology, 10.1016/S1051-0443(00)70174-6, 11:2, (419-423), Online publication date: 1-Feb-2000. JEONG M, AHN Y, CHO J, PARK J, NA K and KANG J (2000) Successful Coronary Stent Implantation Using Local Nitric Oxide Donor Delivery, Journal of Interventional Cardiology, 10.1111/j.1540-8183.2000.tb00288.x, 13:3, (191-195), Online publication date: 1-Jun-2000. An Y and Hubbell J (2000) Intraarterial protein delivery via intimally-adherent bilayer hydrogels, Journal of Controlled Release, 10.1016/S0168-3659(99)00143-1, 64:1-3, (205-215), Online publication date: 1-Feb-2000. Fishbein I, Chorny M, Rabinovich L, Banai S, Gati I and Golomb G (2000) Nanoparticulate delivery system of a tyrphostin for the treatment of restenosis, Journal of Controlled Release, 10.1016/S0168-3659(99)00244-8, 65:1-2, (221-229), Online publication date: 1-Mar-2000. Kipshidze N, Ferguson J, Keelan M, Sahota H, Komorowski R, Shankar L, Chawla P, Haudenschild C, Nikolaychik V and Moses J (2000) Endoluminal reconstruction of the arterial wall with endothelial cell/glue matrix reduces restenosis in an atherosclerotic rabbit, Journal of the American College of Cardiology, 10.1016/S0735-1097(00)00848-2, 36:4, (1396-1403), Online publication date: 1-Oct-2000. Wan W, Lovich M, Hwang C and Edelman E (1999) Measurement of drug distribution in vascular tissue using quantitative fluorescence microscopy, Journal of Pharmaceutical Sciences, 10.1021/js9803858, 88:8, (822-829), Online publication date: 1-Aug-1999. Kalinowski M, Tepe G, Schieber A, Brehme U, Bruck B, Erley C, Claussen C and Duda S (1999) Local Administration of Ramiprilat is Less Effective than Oral Ramipril in Preventing Restenosis after Balloon Angioplasty in an Animal Model, Journal of Vascular and Interventional Radiology, 10.1016/S1051-0443(99)70251-4, 10:10, (1397-1404), Online publication date: 1-Nov-1999. Brooks G and La Thangue N (1999) The cell cycle and drug discovery: the promise and the hope, Drug Discovery Today, 10.1016/S1359-6446(99)01400-2, 4:10, (455-464), Online publication date: 1-Oct-1999. Miraliakbari R, Francalancia N and Chitwood W (1999) Therapeutic angiogenesis: appropriate for clinical use?, Current Surgery, 10.1016/S0149-7944(99)00060-4, 56:4-5, (255-258), Online publication date: 1-May-1999. Kessel D, Wijesinghe L, Robertson L, Scott D, Raat H, Stockx L and Nevelsteen A (1999) Endovascular Stent-Grafts for Superficial Femoral Artery Disease: Results of 1-year Follow-up, Journal of Vascular and Interventional Radiology, 10.1016/S1051-0443(99)70033-3, 10:3, (289-296), Online publication date: 1-Mar-1999. Kibbe M, Billiar T and Tzeng E (1999) Gene Therapy and Vascular Disease , 10.1016/S1054-3589(08)60470-6, (85-150), . Feldman L and Steg P Arterial Gene Transfer Biology of the Arterial Wall, 10.1007/978-0-585-38146-6_13, (259-274) LEE M, SIMON A, STEIN C and RABBANI L (1999) Antisense Strategies to Inhibit Restenosis, Antisense and Nucleic Acid Drug Development, 10.1089/oli.1.1999.9.487, 9:5, (487-492), Online publication date: 1-Oct-1999. Virmani R and Farb A (1999) Pathology of in-stent restenosis, Current Opinion in Lipidology, 10.1097/00041433-199912000-00004, 10:6, (499-506), Online publication date: 1-Dec-1999. Yang Z, Birkenhauer P, Julmy F, Chickering D, Ranieri J, Merkle H, Lüscher T and Gander B (1999) Sustained release of heparin from polymeric particles for inhibition of human vascular smooth muscle cell proliferation, Journal of Controlled Release, 10.1016/S0168-3659(99)00078-4, 60:2-3, (269-277), Online publication date: 1-Aug-1999. Varenne O, Gerard R, Sinnaeve P, Gillijns H, Collen D and Janssens S (1999) Percutaneous Adenoviral Gene Transfer into Porcine Coronary Arteries: Is Catheter-Based Gene Delivery Adapted to Coronary Circulation?, Human Gene Therapy, 10.1089/10430349950018102, 10:7, (1105-1115), Online publication date: 1-May-1999. Wolf Y, Gertz S and Banai S (1999) Animal Models in Syndromes of Accelerated Arteriosclerosis, Annals of Vascular Surgery, 10.1016/S0890-5096(06)61774-3, 13:3, (328-338), Online publication date: 1-May-1999. Radke P, vom Dahl J and Klues H (1999) Stent-Restenose: Therapiekonzepte und Möglichkeiten der PräventionIn-stent restenosis: Therapy and prevention, Medizinische Klinik, 10.1007/BF03044706, 94:2, (88-92), Online publication date: 1-Feb-1999. YAMAGAMI S, MIYAUCHI K, KIMURA T, GOH Y, DAIDA H and YAMAGUCHI H (1999) Effects of the Thromboxane A2 Receptor Antagonist on Platelet Deposition and Intimal Hyperplasia After Balloon Injury., Japanese Heart Journal, 10.1536/jhj.40.791, 40:6, (791-802), . Drachman D, Edelman E and Rogers C (1999) Local Delivery of Antirestenotic Drugs Applications of Antisense Therapies to Restenosis, 10.1007/978-1-4615-5183-6_10, (153-161), . Dangas G and Mehran R (1999) Restenosis Contemporary Concepts in Cardiology, 10.1007/978-1-4615-5007-5_32, (521-537), . Labhasetwar V, Song C, Humphrey W, Shebuski R and Levy R (1998) Arterial Uptake of Biodegradable Nanoparticles: Effect of Surface Modifications, Journal of Pharmaceutical Sciences, 10.1021/js980021f, 87:10, (1229-1234), Online publication date: 1-Oct-1998. Kandarpa K, Nakatsuka S, Yousuf N and Barry J (1998) Site-specific Delivery of Iloprost during Experimental Angioplasty Suppresses Smooth Muscle Cell Proliferation, Journal of Vascular and Interventional Radiology, 10.1016/S1051-0443(98)70305-7, 9:3, (487-493), Online publication date: 1-May-1998. Frishman W, Chiu R, Landzberg B and Weiss M (1998) Medical therapies for the prevention of restenosis after percutaneous coronary interventions, Current Problems in Cardiology, 10.1016/S0146-2806(98)80002-9, 23:10, (533-635), Online publication date: 1-Oct-1998. Song C, Labhasetwar V, Cui X, Underwood T and Levy R (1998) Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: Results with an acute dog model, Journal of Controlled Release, 10.1016/S0168-3659(98)00016-9, 54:2, (201-211), Online publication date: 1-Jul-1998. Adili F, van Eps R, Flotte T and LaMuraglia G (1998) Photodynamic therapy with local photosensitizer delivery inhibits experimental intimal hyperplasia, Lasers in Surgery and Medicine, 10.1002/(SICI)1096-9101(1998)23:5 3.0.CO;2-V, 23:5, (263-273), . Aggarwal R, Ireland D, de Bono D and Gershlick A (2011) In vitro development of the nonthrombogenic stent, International Journal of Angiology, 10.1007/BF01616270, 7:01, (18-21) Hedin U and Wahlberg E (1997) Gene therapy and vascular disease: Potential applications in vascular surgery, European Journal of Vascular and Endovascular Surgery, 10.1016/S1078-5884(97)80004-4, 13:2, (101-111), Online publication date: 1-Feb-1997. Darius H, Buerke M, Boissel J, Grosser T, Veit K, Zacharowski K and Meyer J (1997) Lokale Medikamentengabe und GentherapieLocal drug delivery and gene therapy, Herz, 10.1007/BF03044285, 22:6, (347-354), Online publication date: 1-Dec-1997. Hunter W, Burt H and Machan L (1997) Local delivery of chemotherapy: a supplement to existing cancer treatments, Advanced Drug Delivery Reviews, 10.1016/S0169-409X(97)00035-5, 26:2-3, (199-207), Online publication date: 1-Jul-1997. Herdeg C, Oberhoff M, Baumbach A, Haase K, Horch B, Kranzhoefer A and Karsch K (1997) Local drug delivery with porous balloons in the rabbit: Assessment of vascular injury for an improvement of application parameters, Catheterization and Cardiovascular Diagnosis, 10.1002/(SICI)1097-0304(199707)41:3 3.0.CO;2-J, 41:3, (308-314), Online publication date: 1-Jul-1997. Pavlides G, Barath P, Maginas A, Vasilikos V, Cokkinos D and O'Neill W (1997) Intramural drug delivery by direct injection within the arterial wall: First clinical experience with a novel intracoronary delivery-infiltrator system, Catheterization and Cardiovascular Diagnosis, 10.1002/(SICI)1097-0304(199707)41:3 3.0.CO;2-2, 41:3, (287-292), Online publication date: 1-Jul-1997. Fram D, Mitchel J, Azrin M, Chow M, Waters D and McKay R (1997) Local delivery of heparin to balloon angioplasty sites with a new angiotherapy catheter: Pharmacokinetics and effect on platelet deposition in the porcine model, Catheterization and Cardiovascular Diagnosis, 10.1002/(SICI)1097-0304(199707)41:3 3.0.CO;2-3, 41:3, (275-286), Online publication date: 1-Jul-1997. Reimers B, Moussa I, Akiyama T, Tucci G, Ferraro M, Martini G, Blengino S, DI Mario C and Colombo A (1997) Long-Term Clinical Follow-Up After Successful Repeat Percutaneous Intervention for Stent Restenosis, Journal of the American College of Cardiology, 10.1016/S0735-1097(97)00142-3, 30:1, (186-192), Online publication date: 1-Jul-1997. Hong M, Mehran R, Mintz G and Leon M (1997) Restenosis after coronary angioplasty, Current Problems in Cardiology, 10.1016/S0146-2806(97)80006-0, 22:1, (1-36), Online publication date: 1-Jan-1997. Chambers C, Kozak M, Ettinger S and Gilchrist I (1997) Interventional cardiology: Present and future, Journal of Cardiothoracic and Vascular Anesthesia, 10.1016/S1053-0770(97)90219-6, 11:2, (211-219), Online publication date: 1-Apr-1997. Lincoff A, Furst J, Ellis S, Tuch R and Topol E (1997) Sustained Local Delivery of Dexamethasone by a Novel Intravascular Eluting Stent to Prevent Restenosis in the Porcine Coronary Injury Model, Journal of the American College of Cardiology, 10.1016/S0735-1097(96)00584-0, 29:4, (808-816), Online publication date: 1-Mar-1997. Kandarpa K, Nakatsuka S, Bravo S, Harapanhalli R and Barry J (1997) Mural Delivery of Iloprost with Use of Hydrogel-coated Balloon Catheters Suppresses Local Platelet Aggregation, Journal of Vascular and Interventional Radiology, 10.1016/S1051-0443(97)70701-2, 8:6, (997-1004), Online publication date: 1-Nov-1997. Robinson K, Chronos N, Schieffer E, Palmer S, Cipolla G, Milner P, Walsh R and King S (1997) Pharmacokinetics and tissue localization of antisense oligonucleotides in balloon-injured pig coronary arteries after local delivery with an iontophoretic balloon catheter, Catheterization and Cardiovascular Diagnosis, 10.1002/(SICI)1097-0304(199707)41:3 3.0.CO;2-N, 41:3, (354-359), Online publication date: 1-Jul-1997. Mitchel J, Azrin M, Fram D, Bow L and McKay R (1997) Localized delivery of heparin to angioplasty sites with iontophoresis, Catheterization and Cardiovascular Diagnosis, 10.1002/(SICI)1097-0304(199707)41:3 3.0.CO;2-M, 41:3, (315-323), Online publication date: 1-Jul-1997. Labhasetwar V, Song C and Levy R (1997) Nanoparticle drug delivery system for restenosis, Advanced Drug Delivery Reviews, 10.1016/S0169-409X(96)00483-8, 24:1, (63-85), Online publication date: 1-Feb-1997. Gottsauner-Wolf M, Jang Y, Penn M, Kaplan A, Ellis S, Chisolm G, Topol E and Lincoff A (1997) Quantitative evaluation of local drug delivery using the InfusaSleeve catheter, Catheterization and Cardiovascular Diagnosis, 10.1002/(SICI)1097-0304(199709)42:1 3.0.CO;2-R, 42:1, (102-108), Online publication date: 1-Sep-1997. Faxon D and Currier J (1997) Pharmacologic Perspectives of Remodeling Inhibition Arterial Remodeling: A Critical Factor in Restenosis, 10.1007/978-1-4615-6079-1_25, (519-534), . Ozaki Y and Serruys P (1997) Recent Progress in Coronary Interventions, Japanese Circulation Journal, 10.1253/jcj.61.1, 61:1, (1-13), . Robinson K, Chronos N, Schieffer E, Palmer S, Cipolla G, Milner P and King S (1997) Endoluminal local delivery of PCNA/cdc2 antisense oligonucleotides by porous balloon catheter does not affect neointima formation or vessel size in the pig coronary artery model of postangioplasty restenosis, Catheterization and Cardiovascular Diagnosis, 10.1002/(SICI)1097-0304(199707)41:3 3.0.CO;2-J, 41:3, (348-353), Online publication date: 1-Jul-1997. Eccleston D and Lincoff A (1997) Catheter-based drug delivery for restenosis, Advanced Drug Delivery Reviews, 10.1016/S0169-409X(96)00480-2, 24:1, (31-43), Online publication date: 1-Feb-1997. Beyssac E (1996) The unusual routes of administration, European Journal of Drug Metabolism and Pharmacokinetics, 10.1007/BF03190268, 21:2, (181-187), Online publication date: 1-Jun-1996. Shangguan H, Casperson L, Shearin A, Gregory K and Prahl S (1996) Drug delivery with microsecond laser pulses into gelatin, Applied Optics, 10.1364/AO.35.003347, 35:19, (3347), Online publication date: 1-Jul-1996. Consigny P (1996) Investigations into Restenosis, Journal of Vascular and Interventional Radiology, 10.1016/S1051-0443(96)70069-6, 7:1, (190-193), Online publication date: 1-Jan-1996. Shimabukuro M, Higa S, Shinzato T, Yoshida H, Nagamine F, Takashiba K and Takasu N (1996) Successful repair of intimal dissection following coronary angioplasty with a 48-hour inflation of spiral inflation coil and local delivery of heparin, Catheterization and Cardiovascular Diagnosis, 10.1002/(SICI)1097-0304(199609)39:1 3.0.CO;2-J, 39:1, (103-105), Online publication date: 1-Sep-1996. Liu M, Lin S and Chen Y (1996) Local alcohol delivery may reduce phenotype conversion of smooth muscle cells and neointimal formation in rabbit iliac arteries after balloon injury, Atherosclerosis, 10.1016/S0021-9150(96)05959-X, 127:2, (221-227), Online publication date: 1-Dec-1996. Consigny P (1996) Pharmacological Approaches to Restenosis, Journal of Vascular and Interventional Radiology, 10.1016/S1051-0443(96)70030-1, 7:1, (64-67), Online publication date: 1-Jan-1996. Nikol S, Huehns T and Höfling B (1996) Molecular biology and post-angioplasty restenosis, Atherosclerosis, 10.1016/0021-9150(96)05807-8, 123:1-2, (17-31), Online publication date: 1-Jun-1996. Laurent S, Vanhoutte P, Cavero I, Chabrier P, Dupuis B, Elghozi J, Hamon G, Janiak P, Juillet Y, Kher A, Koen R, Madonna O, Maffrand J, Pruneau D and Thuillez C (1996) The arterial wall: a new pharmacological and therapeutic target, Fundamental & Clinical Pharmacology, 10.1111/j.1472-8206.1996.tb00303.x, 10:3, (243-257), Online publication date: 6-May-1996. Denner L and Dixon R (1995) Chapter 7. Vascular Proliferative Disease , 10.1016/S0065-7743(08)60920-3, (61-70), . Mittal A, Chitkara D, Kumar N, Pawar R, Domb A and Corn B (2016) Regional Drug Therapy: Polymeric Carriers for Encyclopedia of Biomedical Polymers and Polymeric Biomaterials, 10.1081/E-EBPP-120052188, (6951-6972) Kim H (2021) Drug-Coated Balloon for Arteriovenous Access Stenosis in Hemodialysis Patients, Kidney and Dialysis, 10.3390/kidneydial1010004, 1:1, (20-28) October 1, 1994Vol 90, Issue 4 Advertisement Article InformationMetrics Copyright © 1994 by American Heart Associationhttps://doi.org/10.1161/01.CIR.90.4.2070 Originally publishedOctober 1, 1994 PDF download Advertisement

Referência(s)
Altmetric
PlumX